➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Harvard Business School
AstraZeneca
Boehringer Ingelheim
McKesson
Baxter
Express Scripts

Last Updated: June 24, 2021

DrugPatentWatch Database Preview

Triamcinolone acetonide - Generic Drug Details

« Back to Dashboard

What are the generic drug sources for triamcinolone acetonide and what is the scope of freedom to operate?

Triamcinolone acetonide is the generic ingredient in twenty-six branded drugs marketed by Abbvie, Sanofi Aventis Us, Astellas, Ivax Pharms, Delcor Asset Corp, Teva, Solvay, Actavis Mid Atlantic, Alkem Labs Ltd, Alpharma Us Pharms, Ambix, Cosette, Fougera Pharms, Glenmark Pharms Ltd, Lupin, Macleods Pharms Ltd, Morton Grove, Mylan, Perrigo New York, Pharmaderm, Pharmafair, Saptalis Pharms, Strides Pharma, Taro, Taro Pharm Inds Ltd, Teligent, Topiderm, Crown Labs, Savage Labs, Flexion Theraps Inc, Apothecon, Amneal, Parnell, Sandoz Inc, Teva Pharms Usa, Watson Labs, Allergan, Novartis, Akorn, Quagen, Wockhardt Bio Ag, Cintex Svcs, Encube, Glenmark Pharms, Novel Labs Inc, Perrigo Israel, Cmp Pharma Inc, Lyne, Lupin Atlantis, Sun Pharm Inds Inc, Perrigo Uk Finco, and Rising, and is included in one hundred and thirty-one NDAs. There are four patents protecting this compound. Additional information is available in the individual branded drug profile pages.

Triamcinolone acetonide has seventy-five patent family members in twenty-six countries.

There are fifty-one drug master file entries for triamcinolone acetonide. Sixty-four suppliers are listed for this compound.

Drug Prices for triamcinolone acetonide

See drug prices for triamcinolone acetonide

Drug Sales Revenue Trends for triamcinolone acetonide

See drug sales revenues for triamcinolone acetonide

Recent Clinical Trials for triamcinolone acetonide

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Sorrento Therapeutics, Inc.Phase 2
Michael KhazzamPhase 4
Cells for CellsPhase 1/Phase 2

See all triamcinolone acetonide clinical trials

Pharmacology for triamcinolone acetonide
Medical Subject Heading (MeSH) Categories for triamcinolone acetonide

US Patents and Regulatory Information for triamcinolone acetonide

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Astellas ARISTOCORT A triamcinolone acetonide CREAM;TOPICAL 088818-001 Oct 16, 1984 DISCN No No   Try Before You Buy   Try Before You Buy   Try Before You Buy
Astellas ARISTOCORT A triamcinolone acetonide CREAM;TOPICAL 088820-001 Oct 16, 1984 DISCN No No   Try Before You Buy   Try Before You Buy   Try Before You Buy
Savage Labs TRYMEX triamcinolone acetonide CREAM;TOPICAL 088198-001 Mar 25, 1983 DISCN No No   Try Before You Buy   Try Before You Buy   Try Before You Buy
Perrigo Israel TRIAMCINOLONE ACETONIDE triamcinolone acetonide SPRAY, METERED;NASAL 078104-001 Jul 30, 2009 DISCN No No   Try Before You Buy   Try Before You Buy   Try Before You Buy
Lupin Atlantis ALLERNAZE triamcinolone acetonide SPRAY, METERED;NASAL 020120-001 Feb 4, 2000 DISCN No No   Try Before You Buy   Try Before You Buy   Try Before You Buy
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Expired US Patents for triamcinolone acetonide

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Delcor Asset Corp KENALOG-H triamcinolone acetonide CREAM;TOPICAL 086240-001 Approved Prior to Jan 1, 1982   Try Before You Buy   Try Before You Buy
Abbvie AZMACORT triamcinolone acetonide AEROSOL, METERED;INHALATION 018117-001 Apr 23, 1982   Try Before You Buy   Try Before You Buy
Novartis TRIESENCE triamcinolone acetonide INJECTABLE;INTRAVITREAL 022048-001 Nov 29, 2007   Try Before You Buy   Try Before You Buy
Sanofi Aventis Us NASACORT ALLERGY 24 HOUR triamcinolone acetonide SPRAY, METERED;NASAL 020468-002 Oct 11, 2013   Try Before You Buy   Try Before You Buy
Sanofi Aventis Us NASACORT triamcinolone acetonide AEROSOL, METERED;NASAL 019798-001 Jul 11, 1991   Try Before You Buy   Try Before You Buy
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >Patent No. >Patent Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Boehringer Ingelheim
Colorcon
McKesson
Baxter
Express Scripts
Dow

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.